pureheart

September Is Ovarian Cancer Awareness Month

September is Ovarian Cancer Awareness Month, a time of renewed hope
for women who are looking for safe and effective treatment options.
New data suggest that women can live longer and enjoy better quality
of life despite having recurrent or relapsed disease.

Innovative drug therapies demonstrate efficacy with relatively few
side effects (i.e., less hair loss, minimal fatigue, fewer heart
complications) Recent research sharpens focus on treatment strategies
(e.g., combination chemotherapy, sequential therapy with single
agents) New data demonstrating extended survival and improved quality
of life in ovarian cancer will be presented at the largest
international conference on cancer research, the 11th meeting of the
Federation of European Cancer Societies (ECCO), Copenhagen, Denmark,
Sept.
21-25.

WHY:

New treatments and ongoing research provide hope in light of what has
been the most deadly form of gynecologic cancer:

An estimated 25,000 American women will be diagnosed with ovarian
cancer in 2003 More than 14,000 American women will die from ovarian
cancer in
2003 Roughly 75% of ovarian cancers are not diagnosed until the
disease has reached advanced stages and is more difficult to treat
Only about 50% of patients survive beyond five years

WHO:

Ortho Biotech is a resource that can connect you with ovarian cancer
experts and patients who can provide perspective about this disease
and the latest clinical research:

Susana Campos, MD, Dana-Farber Cancer Institute Katharine Kinderman,
ovarian cancer patient advocate

CONTACT:

William Foster

Ortho Biotech Products, LP

908-541-4068

WFoster@GPCUS.JNJ.COMsoetgen@senseihealth.com

CONTACT:

William Foster of Ortho Biotech Products, LP,
+1-908-541-4068,WFoster@GPCUS.JNJ.COM; or Sarah Oetgen of SENSEI
Health, +1-860-828-2044,soetgen@senseihealth.com, for Ortho Biotech
Products, LP

http://news.biocompare.com/newsstory.asp?id=14439